AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned?

Sep 24, 2016 by in NEUROLOGY Comments Off on AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned?

© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_32 32. AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned? Jeffrey H. Kordower1   (1) Department of Neurological Sciences, Rush…

read more

Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders

© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_30 30. Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders Dominic J. Gessler1 and Guangping Gao1   (1) University of…

read more

Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington’s Disease

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington’s Disease

© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_27 27. Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington’s Disease Deborah Young1   (1) Department of Pharmacology & Clinical Pharmacology…

read more

Systemic Gene Therapy for Targeting the CNS

Sep 24, 2016 by in NEUROLOGY Comments Off on Systemic Gene Therapy for Targeting the CNS

Fig. 1 Representative images of mouse brain following systemic injection of AAV9 CB GFP. GFP immunofluorescence shows extensive GFP expression in neurons throughout multiple structures including the cortex (A), hippocampus…

read more

Tissue-Specific Promoters in the CNS

Sep 24, 2016 by in NEUROLOGY Comments Off on Tissue-Specific Promoters in the CNS

Fig. 1 Transcriptional targeting of AAV vectors in the rat striatum. Exclusively neuronal transgene expression is shown after AAV-5-hSYN-EGFP transduction (left panel; shown is an overlay of green = EGFP fluorescence with…

read more

Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection

Sep 24, 2016 by in NEUROLOGY Comments Off on Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection

© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_23 23. Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection James G. Hecker1  …

read more

Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids

Sep 24, 2016 by in NEUROLOGY Comments Off on Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids

© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_10 10. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids Michael J. Castle1, 4, Heikki T. Turunen5, Luk H. Vandenberghe5…

read more
Get Clinical Tree app for offline access